SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs upcoming Q3 earnings report is the main focus, with traders watching guidance, subscriber engagement and advertising growth after a steep share-price decline and recent layoffs and content-leadership changes. Views are split between hopes for a rebound if results or outlook exceed subdued expectations and bets on further losses if growth concerns persist.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is tied to enthusiasm for its Merck-partnered personalized melanoma vaccine after positive Phase 3 topline results, with traders focused on the detailed data presentation at ESMO. Bulls see validation of a broader cancer-vaccine platform and momentum, while bears argue expectations and valuation are stretched and warn of a possible sell-the-news reaction.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Traders are citing a reported ClinicalTrials.gov update adding a site to Sareptas ENHANCE Elevidys safety study as a possible trigger for the rebound, though they note the study timeline reportedly slipped. The broader debate centers on whether upcoming DM1 and FSHD data can support a recovery, with some traders pointing to short covering and others stressing that those clinical results remain unproven.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Seas sharp selloff and fresh low are being linked by traders to plans for a potential Monee listing and the launch of Sea Cloud, alongside concerns about spending and competition in e-commerce. Some see a Monee separation as value-unlocking, while others view the plans and uncertainty around them as a reason to sell; claims of further undisclosed bad news remain speculation.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GEs earnings beat and higher outlook have been met with a sharp selloff, prompting traders to question why strong demand and orders are not lifting the shares. The debate centers on rising costs, weaker cash conversion and an insurance loss, while some investors view the reaction as excessive given the improved guidance.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is drawing attention after its quarterly earnings beat and improved cash-flow outlook failed to prevent a sharp selloff, as traders focused on narrowed full-year profit guidance with no increase to its midpoint. Some see the new buyback and cash generation as support for the shares, while others argue the outlook disappointed despite the strong quarter.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp is driving the sharp rally, with traders viewing the cash proceeds as a potential balance-sheet and strategic reset. Others argue the divestiture removes a significant revenue stream and leaves concerns about debt and weakness in the remaining business; the transaction is still pending approval and closing.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

A sharp COMP rally has sparked breakout talk, with traders pointing to rising momentum, chart patterns, and the tokens limited supply; others remain skeptical, calling it a volatile bounce and questioning whether gains can hold.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention centers on TG Therapeutics MSToronto presentations, especially initial Phase 1 azer-cel data in progressive MS and additional BRIUMVI results, with commercial growth and a future subcutaneous formulation also part of the bullish case. Traders are anticipating a catalyst-driven move, though some caution that the azer-cel results remain uncertain and complain that the shares have struggled to break out of a trading range.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports shares are drawing attention after RAP-219s Phase 2 bipolar-mania trial met its primary and secondary endpoints, prompting bullish reactions and analyst upgrades. Traders are debating whether the efficacy signal is strong enough to justify the surge, citing the modest placebo-adjusted improvement, higher discontinuation rate, and the stocks sharp retreat after its initial jump.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TD And BMO Among 9 Banks Accused Of Discriminating Against Conservative Customers, US Regulator Says

TD And BMO Among 9 Banks Accused Of Discriminating Against Conservative Customers, US Regulator Says

 Authored by Jennifer Cowan via The Epoch Times,

A U.S. banking regulator's report has flagged the Bank of Montreal and TD Bank alongside seven other financial institutions accused of...

All You Need to Know About Bank of Montreal (BMO) Rating Upgrade to Buy

Bank of Montreal (BMO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Is Franklin Resources Inc (BEN) Outperforming Other Finance Stocks This Year?

Here is how Franklin Templeton (BEN) and Bank of Montreal (BMO) have performed compared to their sector so far this year.

BMO Completes Sale of 138 U.S. Branches to First Citizens Bank

BMO Completes Sale of 138 U.S. Branches to First Citizens Bank BMO Completes Sale of 138 U.S. Branches to First Citizens Bank PR Newswire TORONTO and CHICAGO, Sept. 4, 2026 TORONTO and CHICAGO, Sept. 4, 2026 /PRNewswire/ -- BMO Financial Group (TSX: BMO) (NYSE: BMO) today announced the completion...

BMO Financial Group Announces Intention to Repurchase Up to 25 Million of its Common Shares

BMO Financial Group Announces Intention to Repurchase Up to 25 Million of its Common Shares BMO Financial Group Announces Intention to Repurchase Up to 25 Million of its Common Shares PR Newswire TORONTO, Aug. 25, 2026 TORONTO, Aug. 25, 2026 /PRNewswire/ -- Bank of Montreal (TSX: BMO) (NYSE:BMO...

BMO Financial Group Declares Dividends

BMO Financial Group Declares Dividends BMO Financial Group Declares Dividends PR Newswire TORONTO, Aug. 25, 2026 TORONTO, Aug. 25, 2026 /PRNewswire/ -- Bank of Montreal (TSX: BMO) (NYSE: BMO) today announced that its Board of Directors declared a quarterly dividend of $1.71 per share on paid-up...

BMO Financial Group Reports Third Quarter 2026 Results

BMO Financial Group Reports Third Quarter 2026 Results BMO Financial Group Reports Third Quarter 2026 Results PR Newswire TORONTO, Aug. 25, 2026 BMO's Third Quarter 2026 Report to Shareholders, including the unaudited interim consolidated financial statements for the period ended July 31, 2026, are...

Bank of Montreal (BMO) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Bank of Montreal (BMO) have what it takes? Let's find out.

NYSE Content Update: Entry Deadline Nears for The Money Awards 2026

NYSE Content Update: Entry Deadline Nears for The Money Awards 2026 NYSE Content Update: Entry Deadline Nears for The Money Awards 2026 PR Newswire NEW YORK, July 20, 2026 NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, July 20, 2026 /PRNewswire/ -- The New York...

Are Finance Stocks Lagging  Affiliated Managers Group (AMG) This Year?

Here is how Affiliated Managers Group (AMG) and Bank of Montreal (BMO) have performed compared to their sector so far this year.

Provides banking and financial services to individuals and institutions

Bank of Montreal

Bank of Montreal Stock In Focus After $465M Burgundy Asset Deal, Retail’s Split

Equity

Neutral Sentiment

The Bank of Montreal (BMO) has agreed to buy Burgundy Asset Management for C$625 million ($465 million) to bolster its wealth management portfolio.The deal will “strengthen BMO's offering in the Canadian Investment Counsel space, catering to high-net-worth and ultra-high-net-worth clients,” the two companies said on Wednesday.Burgundy has 150 employees serving clients from offices in Toronto, Vancouver, and Montreal. The company has assets under management worth $27 billion as of May 31, 2025.After the deal’s close, expected at the end of the calendar year, Burgundy will operate as part of BMO Wealth Management, and CEO Robert Sankey will continue to lead the business.“In our view, the purchase price of 2.3% of assets under management represents reasonable value to expand BMO’s high-net-worth client base,” John Aiken, equity analyst with Jefferies Financial Group, said, according to Bloomberg.BMO will pay about the purchase price in common shares, including a C$125 million holdback to be paid subject to Burgundy maintaining certain assets under management 18 months post-closing.The lender’s wealth-management unit had about 6,400 employees and C$438 billion under management as of April 30, according to the Bloomberg report. The unit has experienced a surge in activity over the past few months, driven by increased asset inflows.According to Burgundy’s website, more than half of the company’s institutional client business is in Canada, while 37% is in the U.S.Desjardins Securities analyst Doug Young reportedly said that the purchase price was “in line with similar past transactions,” and the deal is a sensible addition in BMO’s plan to reach 15% return on equity in the medium term.Retail sentiment on Stocktwits was in the ‘neutral’ (48/100) territory, while retail chatter was ‘low.’<a href="https://stocktwits.com/symbol/BMO">BMO’s U.S. shares</a> have gained 9.3% this year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/oil-price-surge-halts-after-trump-shuns-immediate-involvement-in-iran-israel-conflict/chlxJuuRRPd">Oil Price Surge Halts After Trump Shuns Immediate Involvement In Iran-Israel Conflict</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Burgundy has assets under management worth $27 billion as of May 31, 2025.

iShares MSCI Canada ETF

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Feed

News

Sentiment

Earnings

Fundamentals

Info

BMO Bank of Montreal

Fundamentals

Latest BMO News